Medicare Benefits and Improvement Act

Medicare Benefits and Improvement Act of 2000 for Outpatient Immunosuppressive Agents... 

Immunosuppressive therapy is life long, or is needed for as long as the individual has a functional transplanted organ, and the cost of therapy often exceeds 10,000 annually. Since the mid-1970s, the question of how to help patients pay for immunosuppressive therapy has received congressional attention. The Medicare Benefits Improvement and Protection Act of 2000 (BIPA 2000) addresses Medicare time limitation for outpatient immunosuppressive coverage. 

---